Assignee
ACORDA THERAPEUTICS INC
US·59 granted patents·83 pending applications·246 citations·filing 1994–2023
Top patents by PatentIndex Score
142 records- 0194US8007826B2Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2004·Granted Aug 30, 2011·29 cites·41 claims
- 0292US9198951B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2013·Granted Dec 1, 2015·10 cites·5 claims
- 0392US8354437B2Method of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2005·Granted Jan 15, 2013·13 cites·40 claims
- 0490US9289501B2Carbonate prodrugs and methods of using the sameACORDA THERAPEUTICS INC·Filed 2015·Granted Mar 22, 2016·6 cites·10 claims
- 0590US2023390261A1Sustained Release Aminopyridine CompositionACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0689US9683000B2Carbonate prodrugs and methods of using the sameACORDA THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·5 cites·1 claims
- 0788US8993545B2Carbonate prodrugs and methods of using the sameACORDA THERAPEUTICS INC·Filed 2014·Granted Mar 31, 2015·6 cites·12 claims
- 0888US2023133230A1Sustained Release Aminopyridine CompositionACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0987US9981998B2Water-soluble acetaminophen analogsACORDA THERAPEUTICS INC·Filed 2016·Granted May 29, 2018·4 cites·24 claims
- 1086US11141467B2Methods of reducing extravasation of inflammatory cellsACORDA THERAPEUTICS INC·Filed 2017·Granted Oct 12, 2021·2 cites·4 claims
- 1186US9956266B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·2 cites·12 claims
- 1285US2022296577A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1384US2024041850A1Methods of Using Sustained Release Aminopyridine CompositionsACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1483US9549893B2Compositions and kits for the removal of irritating compounds from bodily surfacesACORDA THERAPEUTICS INC·Filed 2014·Granted Jan 24, 2017·3 cites·10 claims
- 1583US7662772B2Methods for treating congestive heart failureACORDA THERAPEUTICS INC·Filed 2003·Granted Feb 16, 2010·13 cites·15 claims
- 1683US7485295B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2006·Granted Feb 3, 2009·4 cites·13 claims
- 1783US2022040161A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1882US9024055B2Acetaminophen conjugates, compositions and methods of use thereofACORDA THERAPEUTICS INC·Filed 2012·Granted May 5, 2015·5 cites·9 claims
- 1981US9410141B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·2 cites·16 claims
- 2081US7722864B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2007·Granted May 25, 2010·3 cites·32 claims
- 2181US7037888B1Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 1995·Granted May 2, 2006·60 cites·36 claims
- 2280US9757429B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2016·Granted Sep 12, 2017·2 cites·11 claims
- 2380US8026213B2Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 2010·Granted Sep 27, 2011·3 cites·1 claims
- 2480US2021205282A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2579US9750707B2Methods and compositions for administration of TRPV1 agonistsACORDA THERAPEUTICS INC·Filed 2014·Granted Sep 5, 2017·2 cites·84 claims
- 2679US7731956B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 8, 2010·2 cites·13 claims
- 2778US9102930B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2013·Granted Aug 11, 2015·2 cites·21 claims
- 2878US7968089B2Proteoglycan degrading mutants for the treatment of CNSACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 28, 2011·2 cites·34 claims
- 2978US2020113883A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3078US2020113882A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3177US9329171B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2014·Granted May 3, 2016·2 cites·11 claims
- 3277US2020368217A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3376US10065999B2Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2ACORDA THERAPEUTICS INC·Filed 2014·Granted Sep 4, 2018·1 cites·6 claims
- 3476US7968678B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 28, 2011·1 cites·7 claims
- 3576US2019134016A1Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridineACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3675US11021498B2Water-soluble acetaminophen analogsACORDA THERAPEUTICS INC·Filed 2019·Granted Jun 1, 2021·0 cites·1 claims
- 3775US10717775B2Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2ACORDA THERAPEUTICS INC·Filed 2018·Granted Jul 21, 2020·0 cites·9 claims
- 3875US7718606B2Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 2008·Granted May 18, 2010·1 cites·12 claims
- 3975US6890751B2NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methodsACORDA THERAPEUTICS INC·Filed 2001·Granted May 10, 2005·4 cites·15 claims
- 4075US2019022076A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4175US2011166068A1Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 4275US2019247379A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4374US10232016B2Methods for treating congestive heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted Mar 19, 2019·1 cites·25 claims
- 4474US7115554B1Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF IIIACORDA THERAPEUTICS INC·Filed 1994·Granted Oct 3, 2006·19 cites·35 claims
- 4574US2018153869A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4674US2019314350A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4773US9918973B2Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·0 cites·12 claims
- 4873US9272015B2Method for achieving desired glial growth factor 2 plasma levelsACORDA THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·1 cites·13 claims
- 4973US2020230121A1Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridineACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5073US2019015399A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 142 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →